Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Adcytherix is a biopharmaceutical firm that specializes in the development of new antibody drug conjugates (ADC).
Nuclidium is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics.
Minoryx Therapeutics offers pharmacological chaperones, which are small molecule drugs used for the treatment of genetic diseases.
EvlaBio is a biotech company focused on the development of drug programs that address significant unmet medical needs.
Elkedonia is a biotech company dedicated to transforming antidepressant therapy.
Nuevocor operates as a preclinical-stage biotech company.
Avidicure is pioneering an entirely new dual agonistic, multifunctional and avidity engineered antibody modality.
Brink Therapeutics is a Biotechnology Research firm conducting cell therapy research using reprogrammed recombinases.
Optimized resource planning solution for healthcare institutions
Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.
Omnidoc is a tele-expertise platform for healthcare professionals to exchange medical opinions.
Meiogenix is a biotechnology company that develops breeding technologies.
Radiology augmented GPT to tackle the complexity of precision medicine
PanTera produces actinium-225 for personalized cancer treatment and radiopharmaceuticals.
ImCheck Therapeutics designs and develops immunotherapeutic antibodies for the treatment of cancer and autoimmune disease.
Spotlight Medical develops AI tests to revolutionize cancer treatment, providing everyone with the best possible chance to beat cancer.
SciRhom is a biotech enterprise that translate advanced scientific findings into game-changing therapies for autoimmune diseases.
Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies.
Tacalyx is a biotech company focused on the discovery and development of novel anti-TACA
FeetMe is a digital health company that provides a technology platform for in-clinic and real-world gait and activity assessments.
Safe Orthopaedics is a France-based company principally engaged in the medical devices industry.
BioSerenity provides remote monitoring and diagnostic software for healthcare sectors.
Shorla Pharma is an Irish specialty pharmaceutical company.
Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations.
Kurma Partners has invested in 85 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Kurma Partners's top investment sectors include Health Care, Biotechnology, Medical, Pharmaceutical, Therapeutics. The firm invests across 27 different industry categories.
Among tracked funding rounds, Adcytherix received $122.8M in a Series A round. Kurma Partners's total known invested capital is $2.6B.
Kurma Partners's average investment size is $30.5M across its portfolio of 85 companies.
Recent Kurma Partners portfolio additions include Adcytherix, Nuclidium, Minoryx Therapeutics, EvlaBio, Elkedonia. These companies were founded in 2020 or later.